J Korean Diabetes > Volume 12(4); 2011 > Article
The Journal of Korean Diabetes 2011;12(4):190-193.
DOI: https://doi.org/10.4093/kcd.2011.12.4.190    Published online December 1, 2011.
간기능 이상 당뇨병환자에서 경구혈당강하제의 사용
Use of Oral Hypoglycemic Agents in Type 2 Diabetic Patients with Hepatic Dysfunction.
Ki Young Lee
Devision of Endocrinology and Metabolism, Department of Internal Medicine, Gachon University School of Medicine, Incheon, Korea. ylee@gilhospital.com
The prevalence of type 2 diabetes mellitus in the Korea has increased dramatically over the past decade. Clinicians can prescribe the following six currently available classes of oral hypoglycemic agents: sulfonylureas, meglitinides, biguanides, thiazolidinediones, alpha-glucosidase inhibitors and dipeptidyl peptidase inhibitors. The availability of various oral hypoglycemic agents has given rise to several adverse effects and may result in worse outcomes in patients with comorbid conditions such as liver dysfunction, renal impairment and heart failure. When taking a cross-sectional view of hepatic dysfunction, we find that hepatitis B and alcoholic liver disease are most prevalent in Korea. The use of oral hypoglycemic agents in type 2 diabetic patients with hepatic dysfunction requires many considerations.
Key Words: Type 2 diabetes mellitus, Liver diseases, Hypoglycemic agents, Oral administration

Editorial Office
101-2104, Lotte Castle President, 109 Mapo-daero, Mapo-gu, Seoul 04146, Korea​
Tel: +82-2-714-9064    Fax: +82-2-714-9084    E-mail: diabetes@kams.or.kr                

Copyright © 2024 by Korean Diabetes Association. All rights reserved.

Developed in M2PI

Close layer